EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Seeding Aggregation Assays in Lewy Bodies Disorders: A Narrative State-of-the-Art Review

Anastasia Bougea iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anastasia Bougea. Beteiligte Einrichtung: 1st Department of Neurology, "Aiginition" Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece. Hauptthemen laut MEDLINE: Lewy Body Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple system atrophy and Lewy body diseases (LBDs) such as Parkinson’s disease, dementia with Lewy bodies, and Parkinson’s disease with dementia, known as synucleinopathies, are defined neuropathologically by the accumulation and deposition of aberrant protein aggregates, primarily in neuronal cells. Seeding aggregation assays (SAA) have significant potential as biomarkers for early diagnosis, monitoring disease progression, and evaluating treatment efficacy for these diseases. Real-time quaking-induced conversion (RT-QuIC) and Protein Misfolding Cyclic Amplification (PMCA) assays represent two ultrasensitive protein amplification techniques that were initially tested for the field of prion disorders. Although the fundamental idea behind the creation of these two methods is very similar, their technical differences resulted in different levels of diagnostic accuracy for the identification of prion proteins, making the RT-QuIC assay the most trustworthy and effective instrument for the detection of suspected cases of LBDs and prion-like diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body DiseaseHumansBiomarkersAnimalsPrion ProteinsProtein Aggregation, PathologicalParkinson DiseaseProtein Foldingalpha-SynucleinProtein Aggregates

Stichwörter der Autor:innen

Lewy body disease (LBD)alpha-synucleinprion-like diseasesprotein misfolding cyclic amplification PMCAreal-time quaking-induced conversion (RT-QuIC)seed amplification assay (SAA)

Substanzen

BiomarkersPrion Proteinsalpha-SynucleinProtein Aggregates

Autor:innen und Institutionen

  • 1st Department of Neurology, "Aiginition" Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.

ORCID-Profile: Anastasia Bougea

Zitieren

APA

Bougea, A. (2024). Seeding Aggregation Assays in Lewy Bodies Disorders: A Narrative State-of-the-Art Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910783

Vancouver

Bougea A. Seeding Aggregation Assays in Lewy Bodies Disorders: A Narrative State-of-the-Art Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910783

BibTeX
@article{Bougea2024,
  author = {Bougea, Anastasia},
  title = {Seeding Aggregation Assays in Lewy Bodies Disorders: A Narrative State-of-the-Art Review},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910783}
}
Kostenlos starten →